Statistics and Its Interface, issn 1938-7989, published by INT PRESS BOSTON, INC, is a vital academic journal dedicated to bridging the critical intersection of statistics, applied mathematics, and interdisciplinary research. With its inaugural publication in 2011, this journal has continually aimed to provide a platform for innovative statistical methods and their application across various fields, offering valuable insights for researchers and practitioners alike. While the journal currently operates without an open access model, it maintains an essential position within the scholarly community, evidenced by its 2023 rankings in the third quartile for Applied Mathematics and the fourth quartile for Statistics and Probability. Furthermore, it holds a respectable position in Scopus rankings, reflecting its commitment to quality over quantity. By publishing cutting-edge research, Statistics and Its Interface serves as a critical resource for advancing statistical knowledge and cultivating a deeper understanding of its applications in real-world contexts.

Therapeutic Innovation & Regulatory Science, published by Springer Heidelberg, is an esteemed journal that focuses on the intersection of therapeutic innovations and the regulatory frameworks that govern them. Established in 1970 and continuing its legacy of excellence through converged years, this journal plays a crucial role in supplying cutting-edge research, reviews, and discussions that advance understanding in the fields of pharmacology and healthcare regulation. With an impact factor reflective of its rigorous peer-review standards, this journal holds a prestigious Q1 ranking in Pharmacology, Toxicology, and Pharmaceutics (Miscellaneous) for 2023, reflecting its influence and the high quality of its published material. The journal's wide scope also embraces public health and environmental studies, making it an essential resource for researchers and professionals navigating these critical areas. Open access options enhance its visibility and accessibility, ensuring that the latest discoveries and regulatory insights are readily available to a global audience. For those at the forefront of medicinal science and regulatory affairs, Therapeutic Innovation & Regulatory Science is your avenue to understanding pivotal innovations that shape contemporary therapeutic practices.

The International Journal of Biostatistics, published by Walter de Gruyter GmbH, stands as a critical platform for advancements in the fields of biostatistics and applied statistics in medicine. With an ISSN of 2194-573X and an E-ISSN of 1557-4679, this journal has gained recognition for its rigorous peer-reviewed articles that bridge theoretical statistics and its practical applications in health sciences, maintaining a commendable Q2 quartile ranking in both Medicine and Statistics categories as of 2023. Hosted in Germany, the journal's pivotal role lies in disseminating innovative research findings that guide public health decisions and inform healthcare policy, thus appealing to a diverse readership including researchers, healthcare professionals, and students. Although the journal operates under a subscription model, it remains committed to providing valuable insights into the statistical methods that support evidence-based medicine and improve health outcomes globally. For those engaged in the evolving landscape of biostatistics, the International Journal of Biostatistics serves as an indispensable resource through its comprehensive coverage from 2005 to 2024.

Contemporary Clinical Trials Communications, published by ELSEVIER INC, serves as a pivotal resource in the evolving fields of medicine and pharmacology, especially with its commitment to open access since 2015. With the E-ISSN 2451-8654, this journal is dedicated to disseminating high-quality research that examines contemporary clinical trial methodologies and their applications in improving healthcare outcomes. Situated in the United States, its impressive ranking, with a Q2 status in both Medicine (miscellaneous) and Pharmacology for 2023, highlights its significance and impact within the scientific community. Ranking #199 out of 636 in General Medicine and #217 out of 313 in Pharmacology on the Scopus scale, the journal aims to foster innovative discussions and developments among researchers, professionals, and students, making it an essential tool for those seeking to stay at the forefront of clinical research and trials.

Journal of Survey Statistics and Methodology, published by Oxford University Press Inc, is a pivotal platform for advancing research in the fields of Applied Mathematics, Social Sciences, and Statistics. With its ISSN 2325-0984 and E-ISSN 2325-0992, this journal has firmly established itself since its inception in 2013, achieving a remarkable Q1 quartile ranking across various disciplines in 2023, indicating its significant impact and prestige in the academic community. It serves as a key resource for researchers and practitioners committed to enhancing survey methodology, statistical practices, and data-driven decision-making processes. The journal provides a comprehensive assembly of scholarly articles, methodological advancements, and theoretical insights, aimed at enriching the landscape of survey statistics and related domains. Scholars are encouraged to contribute and stay abreast of the latest findings that shape the future of survey research and methodology.

Journal of Biopharmaceutical Statistics, published by Taylor & Francis Inc, is a premier scholarly journal that has been contributing to the fields of biostatistics and pharmacology since its inception in 1991. With an impressive track record spanning over three decades, it holds a significant place in the academic landscape, particularly evidenced by its Q2 quartile rankings in Pharmacology, Pharmacology (Medical), and Statistics and Probability as of 2023. The journal serves as a vital platform for researchers, professionals, and students, disseminating critical statistical methodologies and innovative analyses that enhance drug development and biopharmaceutical research. Although not open access, it provides invaluable insights through meticulously peer-reviewed articles that tackle pressing issues in pharmacometric modeling, clinical trial design, and statistical theory. As the biopharmaceutical industry evolves, Journal of Biopharmaceutical Statistics remains pivotal in fostering scientific discovery and excellence.

STATISTICS & PROBABILITY LETTERS is a distinguished journal published by ELSEVIER, dedicated to advancing the field of statistics and probability. With an ISSN of 0167-7152 and an E-ISSN of 1879-2103, this journal is an essential platform for research, featuring cutting-edge studies and significant findings in the realms of statistical theory and applied probability. The journal operates under a notable Q3 ranking in both the categories of Statistics and Probability, and Statistics, Probability and Uncertainty for 2023, underscoring its relevance in these fields. Researchers, professionals, and students alike benefit from its rigorous peer-review process and its commitment to published integrity, fostering innovative insights from 1982 through its anticipated convergence in 2025. While it does not offer open access, the journal’s widely recognized impact within the academic community makes it a valuable resource for anyone seeking to deepen their understanding of statistical methodologies and probabilistic models.

SCANDINAVIAN JOURNAL OF STATISTICS is a premier publication in the field of statistics, published by Wiley. With an impressive impact factor that reflects its influence, this journal is recognized for its rigorous peer-reviewed research articles that contribute to the advancement of statistical methods and their applications. As a leading resource, the journal spans a wide range of topics within Statistics and Probability, maintaining a strong scholarly presence with a Q1 rank in Statistics and Probability and a Q2 rank in Statistics, Probability and Uncertainty as per the 2023 category quartiles. The journal has been diligently publishing high-quality research since 1996, and now encompasses studies up to 2024, reinforcing its commitment to providing valuable insights for researchers, professionals, and students alike. While the journal does not offer open access, it remains an essential repository of knowledge in statistical sciences, fostering collaboration and innovation within the global academic community.

AUSRALIAN & NEW ZEALAND JOURNAL OF STATISTICS, published by Wiley, stands as a significant platform for the dissemination of statistical knowledge and applications, specifically within the realms of statistics and probability. With an impact factor reflective of its quality and standing, the journal operates in a Q3 category for both Statistics and Probability, as well as Statistics, Probability, and Uncertainty, positioning it among the important scholarly resources in its field. As a valuable resource for researchers, professionals, and students, the journal encourages the submission of innovative research articles that push the boundaries of statistical science. Offering both print and open access options, it ensures broad accessibility, promoting a culture of collaboration and knowledge sharing across the global statistical community. Covering research from 1998 to 2024, it remains dedicated to advancing understanding in statistical methodologies and their applications, cementing its role in fostering academic discourse and practical advancements in the field.

Contemporary Clinical Trials, published by Elsevier Science Inc, stands at the forefront of clinical research, providing a dedicated platform for the dissemination of innovative studies and methodologies in medicine and pharmacology. With an impressive impact factor reflecting its consistent contributions to the field, this journal is categorized in the Q1 quartile for both Medicine (miscellaneous) and Pharmacology (medical) as of 2023. The journal's scope encompasses a broad range of topics pertinent to clinical trial design, execution, and analysis, aiming to enhance the effectiveness and safety of therapeutic interventions. Operating under an Open Access model, it ensures that the latest research is accessible to a global audience, fostering collaboration and discussion among researchers, professionals, and students alike. In publishing high-quality articles since its inception in 2005, Contemporary Clinical Trials continues to shape the future of clinical research with its commitment to excellence and innovation.